NCT02718651View on ClinicalTrials.gov

Blood-based Identification and Monitoring of Patients With ALK-translocated Lung Cancer

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (1)

8000

Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

lead

University of Aarhus

OTHER

NCT02718651 - Blood-based Identification and Monitoring of Patients With ALK-translocated Lung Cancer | Biotech Hunter | Biotech Hunter